Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background Sleep difficulty is a common symptom of cannabis withdrawal, but little research has objectively measured sleep or explored the effects of hypnotic medication on sleep during cannabis withdrawal. Methods Twenty daily cannabis users completed a within-subject crossover study. Participants alternated between periods of ad-libitum cannabis use and short-term cannabis abstinence (3 days). Placebo was administered at bedtime during one abstinence period (withdrawal test) and extended-release zolpidem, a non-benzodiazepine GABAA receptor agonist, was administered during the other. Polysomnographic (PSG) sleep architecture measures, subjective ratings, and cognitive performance effects were assessed each day. Results During the placebo-abstinence period, participants had decreased sleep efficiency, total sleep time, percent time spent in Stage 1 and Stage 2 sleep, REM latency and subjective sleep quality, as well as increased sleep latency and time spent in REM sleep compared with when they were using cannabis. Zolpidem attenuated the effects of abstinence on sleep architecture and normalized sleep efficiency scores, but had no effect on sleep latency. Zolpidem was not associated with any significant side effects or next-day cognitive performance impairments. Conclusions These data extend prior research that indicates abrupt abstinence from cannabis can lead to clinically significant sleep disruption in daily users. The findings also indicate that sleep disruption associated with cannabis withdrawal can be attenuated by zolpidem, suggesting that hypnotic medications might be useful adjunct pharmacotherapies in the treatment of cannabis use disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
Wagner, U., Gais, S., & Born, J. (2001) · Learning & Memory · doi:10.1101/lm.36801 · Cited by 605 · cited 1×
“REM sleep is increasingly believed to play a role in affect regulation and memory related processes (Stickgold and Walker, 2007; Wagner et al., 2001; Walher, 2010).”
BackgroundMarijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348 · cited 4×
“The Marijuana Withdrawal Checklist (MWC) (Budney et al., 1999) was used to assess the presence of cannabis withdrawal symptoms during prior periods of abstinence.”
BackgroundMethodInfluentialSelf-citationSleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances
Brower, K. J., & Perron, B. E. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.10.020 · Cited by 226 · cited 1×
“Significant sleep disruption appears to be a common feature of withdrawal across drugs of abuse, and it has been suggested that sleep disturbance is a universal risk factor for relapse among those with drug use disorders (Brower and Perron, 2010).”
BackgroundPolysomnographic and subjective sleep predictors of alcoholic relapse
Brower, K. J., Aldrich, M. S., & Hall, J. M. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03995.x · Cited by 223
Reliability and validity of a short form of the Marijuana Craving Questionnaire
Heishman, S. J., Evans, R. J., Singleton, E. G., Levin, K. H., Copersino, M. L., & Gorelick, D. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.12.010 · Cited by 212
Edinger, J. D., Means, M. K., Carney, C. E., & Krystal, A. D. (2008) · Sleep · doi:10.1093/sleep/31.5.599 · Cited by 168
Cited by
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Babson, K. A., Sottile, J., & Morabito, D. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0775-9 · Cited by 484
Angarita, G. A., Emadi, N., Hodges, S., & Morgan, P. T. (2016) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0056-7 · Cited by 358
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“A laboratory study of extended-release zolpidem (Vandrey et al., 2011) demonstrated that zolpidem attenuated the effects of cannabis withdrawal on sleep architecture, and improved sleep efficiency but not sleep latency.”
BackgroundHealth economics of insomnia treatments: The return on investment for a good night's sleep
Wickwire, E. M., Shaya, F. T., & Scharf, S. M. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.11.004 · Cited by 287
The cannabis withdrawal syndrome: current insights
Bonnet, U., & Preuss, U. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s109576 · Cited by 221
“…that is assumed to be most associated with relapse to cannabis use, 105 a few sleeping medications were tested in the CWS treatment with first promising results for mirtazapine 30 and zolpidem 106,107 during the first days of abstinence, necessarily taking care for zolpidem’s potential misuse.”
Metadata
- Authors
- Vandrey, R., Smith, M. T., McCann, U. D., Budney, A. J., & Curran, E. M.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 117
- Issue
- 1
- Pages
- 38-44
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W1975069582
- Cited by
- 116
- References
- 7
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2011.01.003
- The paper
- Vandrey, R., Smith, M. T., McCann, U. D., Budney, A. J., & Curran, E. M. (2011). Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2011.01.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.